Shanghai Chenguang Medical Technologies Co (BJSE:920300) Piotroski F-Score: 4 (As of Aug. 21, 2026) — 20% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920300 Shanghai Chenguang Medical Technologies Co Ltd BJSE:920300
53 GF Score
Price ¥9.47
GF Value ¥6.57
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Shanghai Chenguang Medical Technologies Co Piotroski F-Score?

Shanghai Chenguang Medical Technologies Co BJSE:920300 53 Piotroski F-Score is 4 as of Aug. 21, 2026, which is 20% below its 10-year median of 5.00. GuruFocus rates BJSE:920300 with a GF Score™ of 53/100 and a GF Value™ of ¥6.57 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 2,963 Industrial Products companies, Shanghai Chenguang Medical Technologies Co ranks worse than 65.71% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai Chenguang Medical Technologies Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Shanghai Chenguang Medical Technologies Co's Piotroski F-Score or its related term are showing as below:

BJSE:920300' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 5   Max: 8
Current: 4

During the past 13 years, the highest Piotroski F-Score of Shanghai Chenguang Medical Technologies Co was 8. The lowest was 1. And the median was 5.

Shanghai Chenguang Medical Technologies Co  (BJSE:920300) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shanghai Chenguang Medical Technologies Co Piotroski F-Score Related Terms


Shanghai Chenguang Medical Technologies Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Shanghai Chenguang Medical Technologies Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Chenguang Medical Technologies Co Piotroski F-Score Chart

Shanghai Chenguang Medical Technologies Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 4.00 0.00 3.00 4.00

Shanghai Chenguang Medical Technologies Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 5.00 5.00 4.00 4.00

BJSE:920300 vs VRT, BE: Piotroski F-Score Comparison

For the Electrical Equipment & Parts subindustry, Shanghai Chenguang Medical Technologies Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Chenguang Medical Technologies Co Piotroski F-Score vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Shanghai Chenguang Medical Technologies Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Shanghai Chenguang Medical Technologies Co's Piotroski F-Score falls into.


BJSE:920300
53GF Score
Shanghai Chenguang Medical Technologies Co Ltd BJSE:920300
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -6.235 + -4.513 + -41.109 + -7.276 = ¥-59.13 Mil.
Cash Flow from Operations was 7.081 + 9.745 + -6.696 + 3.536 = ¥13.67 Mil.
Revenue was 22.278 + 20.39 + 22.197 + 24.678 = ¥89.54 Mil.
Gross Profit was 14.113 + 11.841 + 13.158 + 10.152 = ¥49.26 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(432.625 + 415.025 + 405.207 + 348.984 + 340.757) / 5 = ¥388.5196 Mil.
Total Assets at the begining of this year (Mar25) was ¥432.63 Mil.
Long-Term Debt & Capital Lease Obligation was ¥42.58 Mil.
Total Current Assets was ¥182.72 Mil.
Total Current Liabilities was ¥125.15 Mil.
Net Income was -2.152 + -4.668 + -45.023 + -8.583 = ¥-60.43 Mil.

Revenue was 36.296 + 28.951 + 32.895 + 25.074 = ¥123.22 Mil.
Gross Profit was 13.815 + 11.051 + 9.971 + 7.733 = ¥42.57 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(463.379 + 492.393 + 497.635 + 441.465 + 432.625) / 5 = ¥465.4994 Mil.
Total Assets at the begining of last year (Mar24) was ¥463.38 Mil.
Long-Term Debt & Capital Lease Obligation was ¥19.85 Mil.
Total Current Assets was ¥240.68 Mil.
Total Current Liabilities was ¥179.09 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai Chenguang Medical Technologies Co's current Net Income (TTM) was -59.13. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai Chenguang Medical Technologies Co's current Cash Flow from Operations (TTM) was 13.67. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-59.133/432.625
=-0.1366842

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-60.426/463.379
=-0.13040297

Shanghai Chenguang Medical Technologies Co's return on assets of this year was -0.1366842. Shanghai Chenguang Medical Technologies Co's return on assets of last year was -0.13040297. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shanghai Chenguang Medical Technologies Co's current Net Income (TTM) was -59.13. Shanghai Chenguang Medical Technologies Co's current Cash Flow from Operations (TTM) was 13.67. ==> 13.67 > -59.13 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=42.583/388.5196
=0.10960322

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=19.85/465.4994
=0.04264238

Shanghai Chenguang Medical Technologies Co's gearing of this year was 0.10960322. Shanghai Chenguang Medical Technologies Co's gearing of last year was 0.04264238. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=182.718/125.146
=1.46003867

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=240.678/179.087
=1.34391664

Shanghai Chenguang Medical Technologies Co's current ratio of this year was 1.46003867. Shanghai Chenguang Medical Technologies Co's current ratio of last year was 1.34391664. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shanghai Chenguang Medical Technologies Co's number of shares in issue this year was 90.949. Shanghai Chenguang Medical Technologies Co's number of shares in issue last year was 85.827. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=49.264/89.543
=0.55017143

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=42.57/123.216
=0.34549085

Shanghai Chenguang Medical Technologies Co's gross margin of this year was 0.55017143. Shanghai Chenguang Medical Technologies Co's gross margin of last year was 0.34549085. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=89.543/432.625
=0.20697602

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=123.216/463.379
=0.2659076

Shanghai Chenguang Medical Technologies Co's asset turnover of this year was 0.20697602. Shanghai Chenguang Medical Technologies Co's asset turnover of last year was 0.2659076. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+0+1+0+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai Chenguang Medical Technologies Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Shanghai Chenguang Medical Technologies Co (BJSE:920300) has a Piotroski F-Score of 4 as of Aug. 21, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai Chenguang Medical Technologies Co and its competitors. This is 20% below median its historical median of 5.00. Over the past decade, Shanghai Chenguang Medical Technologies Co's Piotroski F-Score has ranged from 1.00 to 8.00. According to the industry distribution chart, Shanghai Chenguang Medical Technologies Co ranks #1947 out of 2963 companies in the Industrial Products industry, placing it in the top 65.7%.
Is Shanghai Chenguang Medical Technologies Co's Piotroski F-Score too high?
Shanghai Chenguang Medical Technologies Co's current Piotroski F-Score of 4 is 20% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 8.00. The Industrial Products industry median Piotroski F-Score is 5.00. Shanghai Chenguang Medical Technologies Co's value of 4 is 20% below this industry median. Based on the distribution chart, Shanghai Chenguang Medical Technologies Co ranks #1947 out of 2963 companies in the Industrial Products industry, which is below the industry midpoint. Overall, Shanghai Chenguang Medical Technologies Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Chenguang Medical Technologies Co's Piotroski F-Score compare to VRT and BE?
According to the Industrial Products industry distribution chart, Shanghai Chenguang Medical Technologies Co ranks #1947 out of 2963 companies for Piotroski F-Score. This places Shanghai Chenguang Medical Technologies Co in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Shanghai Chenguang Medical Technologies Co's value of 4 is 20% below this benchmark. Historically, Shanghai Chenguang Medical Technologies Co's own Piotroski F-Score has ranged from 1.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Shanghai Chenguang Medical Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for an Industrial Products company?
The median Piotroski F-Score among Industrial Products companies is 5.00, based on 2,963 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Chenguang Medical Technologies Co's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai Chenguang Medical Technologies Co and its competitors. For the Industrial Products industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Chenguang Medical Technologies Co's current Piotroski F-Score is 4, which is 20% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Chenguang Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co (BJSE:920300) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥6.57, compared to a current price of ¥9.47 — trading 44.1% above its estimated fair value. The current Piotroski F-Score is 4, which is 20% below median its 10-year median of 5.00 and 20% below the Industrial Products industry median of 5.00. Shanghai Chenguang Medical Technologies Co's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Shanghai Chenguang Medical Technologies Co (BJSE:920300), the current Piotroski F-Score is 4 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Chenguang Medical Technologies Co (BJSE:920300) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co stock appears to be overvalued. The current stock price of ¥9.47 is trading 44.1% above its estimated GF Value™ of ¥6.57. GuruFocus considers Shanghai Chenguang Medical Technologies Co to be Significantly Overvalued.

Key valuation signals for BJSE:920300:

  • Piotroski F-Score: 4 (20% below median its 10-year median of 5.00)
  • GF Value™: ¥6.57 vs. price of ¥9.47 (44.1% above fair value)
  • GF Score™: 53/100 with 6 warning signs
  • Industry Position: 20% below the Industrial Products median (#1947 of 2963)

No single metric tells the full story. See the BJSE:920300 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Chenguang Medical Technologies Co Business Description

Address No. 1269, Huaqing Road, Qingpu District, Shanghai, CHN, 201707
Shanghai Chenguang Medical Technologies Co Ltd engages in research and development, production, and sales of the core hardware of medical imaging superconducting MRI equipment and special magnets in the field of scientific research. The company's product system covers hardware of superconducting MRI devices, including: RF detectors, superconducting magnets, gradient coils, RF amplifiers, gradient amplifiers.
53GF Score

Get the complete analysis for BJSE:920300

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.47
Price
¥6.57
GF Value